Related Experiment Videos
Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance
1Division of Occupational Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. robert.winker@meduniwien.ac.at
International Archives of Occupational and Environmental Health
|February 19, 2005
Summary
The beta1Gly49 genetic polymorphism appears to protect against idiopathic orthostatic intolerance (IOI). This finding suggests that specific gene variants may influence the development of IOI symptoms.
Area of Science:
- Cardiovascular Genetics
- Autonomic Nervous System Research
- Pharmacogenomics
Background:
- Idiopathic orthostatic intolerance (IOI) involves chronic symptoms like tachycardia and increased norepinephrine upon standing.
- These symptoms may stem from altered adrenergic receptor function within the sympathetic nervous system.
Purpose of the Study:
- To investigate if genetic variations in adrenergic receptor genes influence the risk of developing IOI.
- Specifically examined eight polymorphic loci in alpha2A, alpha2B, alpha2C, beta1, and beta2 adrenergic receptor genes.
Main Methods:
- Studied 80 young men (20 with IOI, 60 controls) using tilt table tests.
- Monitored blood pressure, heart rate, and plasma catecholamines during supine and standing positions.
- Genotyped participants at eight specific adrenergic receptor loci and analyzed associations with IOI and hemodynamic variables.
Main Results:
- The beta1Gly49 polymorphism showed a decreased risk of IOI in homozygous individuals (OR, 0.88).
- This polymorphism was also associated with a lower heart rate when upright, irrespective of IOI diagnosis.
- No significant associations were found between other tested polymorphisms and IOI risk.
Conclusions:
- The beta1Gly49 polymorphism appears to be a protective factor against idiopathic orthostatic intolerance.
- This genetic variant likely contributes to modifying IOI phenotypes, potentially alongside other genetic factors.